Articles Accepted

QUANTIFICATION OF PYRAZINAMIDE IN HUMAN PLASMA: DEVELOPMENT AND VALIDATION OF AN LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY METHOD
by Dr. Celina Nazareth, 04 Dec 2024
Co-Author(s): Erica Alves,Raman Batheja,Reuben Nazareth

ABSTRACT A simple and efficient liquid chromatography-tandem mass spectrometry method was established to quantify pyrazinamide in human plasma, using pyrazinamide D3 as the internal standard. Plasma samples were extracted with Hi-purity MCX cartridges via solid phase extraction. Chromatographic separation of pyrazinamide and the internal standard was performed on a Hypurity C8 column (100×4.6mm, 5µ) using isocratic conditions at 30 ºC. The mobile phase consisted of an organic mixture and 10 mM ammonium acetate (50:50 v/v) at a flow rate of 1 mL/min. Pyrazinamide and the internal standard eluted at 1.44 and 1.43 minutes, respectively, within a 3-minute runtime. Detection employed the use a Hypurity HPLC column coupled with an AB Sciex API 4000 tandem mass spectrometer with electrospray ionization. Pyrazinamide was detected via ion transition 124.2 to 81, while the IS used ion transition 127.2 to 84. The method was validated per European Medicine Agency (EMA) guidelines, meeting acceptance criteria.

Current Issue
June 2025
Quick Contact